1. Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA;
2. Harvard Stem Cell Institute, Harvard University, Boston, MA;
3. Cancer Science Institute of Singapore, National University of Singapore, Singapore;
4. Chemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA;
5. Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria;
6. Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;
7. Division of Hematology, Department of Medicine I, Medical University of Vienna, Vienna, Austria;
8. Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy;
9. Saint Camillus International University of Health Sciences, Rome, Italy;
10. Stanford University School of Medicine, Stanford, CA;
11. University of Florida, Gainesville, FL;
12. Institute of Biomedical Technologies, National Research Council (CNR), Area della Ricerca di Pisa, Pisa, Italy;
13. Department of Pathology, Beth Israel Deaconess Cancer Center, Harvard Medical School Boston, MA;
14. Division of Translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan;
15. Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA;
16. Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA; and
17. Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy